The authors assert that the time is ripe for the United States and Europe to take the lead on shepherding a systems-level change in the recycling market, strengthened by government regulation and legislation. They examine the economic, social, and environmental impacts of mismanaged waste and argue that the Covid-19 pandemic could serve as a catalyst for action toward a global, circular economy.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.